Advanced search
Publication Cover
The European Journal of Contraception & Reproductive Health Care Volume 16, 2011 - Issue 2
Submit an article Journal homepage
254
Views
27
CrossRef citations to date
0
Altmetric
Original Research Articles

Inhibition of ovulation by NOMAC/E2, a novel monophasic oral contraceptive combining nomegestrol acetate and 17β-oestradiol: A double-blind, randomised, dose-finding pilot study

Nathalie Chabbert-Buffet Obstetrics and Gynaecology Unit, Hôpital Tenon AP-HP, and ER-9, UPMC Université Paris 06, Paris, France
,
Didier Chassard SGS Aster, Paris, France
,
Edith Ochsenbein Laboratoire Théramex SAM, Monaco
,
Jean-Louis Thomas Laboratoire Théramex SAM, MonacoCorrespondence[email protected]
&
Sophie Christin-Maitre AP-HP Endocrinology Department, Hôpital Saint Antoine and ER-9, UPMC Université Paris 06, Paris, France
Pages 76-84 | Published online: 21 Feb 2011

Citations (27)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (11)

Carlo Bastianelli, Manuela Farris, Elena Rosato, Ivo Brosens & Giuseppe Benagiano. (2018) Pharmacodynamics of combined estrogen-progestin oral contraceptives 3. Inhibition of ovulation. Expert Review of Clinical Pharmacology 11:11, pages 1085-1098.
Read now
Manuela Neri, Maria Elena Malune, Valentina Corda, Bruno Piras, Pierina Zedda, Monica Pilloni, Maria Paola Orani, Valerio Vallerino, Gian Benedetto Melis & Anna Maria Paoletti. (2017) Body composition and psychological improvement in healthy premenopausal women assuming the oral contraceptive containing micronized estradiol (E2) and nomegestrol acetate (NOMAC). Gynecological Endocrinology 33:12, pages 958-962.
Read now
Hannat Akintomide & Sabeena Panicker. (2015) Nomegestrol acetate/17-beta estradiol: a review of efficacy, safety, and patient acceptability. Open Access Journal of Contraception 6, pages 77-86.
Read now
Anita L Nelson. (2015) An update on new orally administered contraceptives for women. Expert Opinion on Pharmacotherapy 16:18, pages 2759-2772.
Read now
Anne Burke. (2013) Nomegestrol acetate-17b-estradiol for oral contraception. Patient Preference and Adherence 7, pages 607-619.
Read now
Jeffrey T Jensen, Johannes Bitzer & Marco Serrani. (2013) Comparison of the pharmacologic and clinical profiles of new combined oral contraceptives containing estradiol. Open Access Journal of Contraception 4, pages 39-50.
Read now
Krzysztof Jonderko, Piotr Skałba, Magdalena Kamińska, Anna Kasicka-Jonderko, Ewa Galas & Aleksandra Biały. (2013) Combined oral contraceptives affect liver mitochondrial activity. The European Journal of Contraception & Reproductive Health Care 18:5, pages 401-409.
Read now
Nathalie Chabbert-Buffet, Jan Gerris, Christian Jamin, Stefano Lello, Inaki Lete, Paloma Lobo, Rossella E. Nappi & Axelle Pintiaux. (2013) Toward a new concept of “natural balance” in oral estroprogestin contraception. Gynecological Endocrinology 29:10, pages 891-896.
Read now
Krzysztof Jonderko, Piotr Skałba, Anna Kasicka-Jonderko, Magdalena Kamińska, Dorota Bizior-Frymus & Renata Dyja. (2013) Impact of combined oral contraceptives containing ethinylestradiol on the liver microsomal metabolism. The European Journal of Contraception & Reproductive Health Care 18:4, pages 284-292.
Read now
Franca Fruzzetti, Florence Trémollieres & Johannes Bitzer. (2012) An overview of the development of combined oral contraceptives containing estradiol: focus on estradiol valerate/dienogest. Gynecological Endocrinology 28:5, pages 400-408.
Read now
Lee P Shulman & Jessica W Kiley. (2011) Oral contraception: from birth control to pregnancy prevention with noncontraceptive benefits. Expert Review of Obstetrics & Gynecology 6:5, pages 539-550.
Read now

Articles from other publishers (16)

Jacques Donnez. (2020) Uterine Fibroids and Progestogen Treatment: Lack of Evidence of Its Efficacy: A Review. Journal of Clinical Medicine 9:12, pages 3948.
Crossref
Diana Mansour, Carolyn Westhoff, Uma Kher & Tjeerd Korver. (2017) Pooled analysis of two randomized, open-label studies comparing the effects of nomegestrol acetate/17?-estradiol and drospirenone/ethinyl estradiol on bleeding patterns in healthy women. Contraception 95:4, pages 390-397.
Crossref
Justine Hugon-Rodin, Anne Gompel & Geneviève Plu-Bureau. (2014) MECHANISMS IN ENDOCRINOLOGY: Epidemiology of hormonal contraceptives-related venous thromboembolism. European Journal of Endocrinology 171:6, pages R221-R230.
Crossref
Anne Gompel & Genevieve Plu-Bureau. (2014) Are we overestimating the stroke risk related to contraceptive pills?. Current Opinion in Neurology 27:1, pages 29-34.
Crossref
Lee P Shulman. (2013) Changing convention in combination oral contraceptives: estradiol and nomegestrol acetate in a monophasic 24/4 regimen. Journal of Family Planning and Reproductive Health Care 39:3, pages 211-216.
Crossref
Frank Z. Stanczyk, David F. Archer & Bhagu R. Bhavnani. (2013) Ethinyl estradiol and 17β-estradiol in combined oral contraceptives: pharmacokinetics, pharmacodynamics and risk assessment. Contraception 87:6, pages 706-727.
Crossref
Genevi?ve Plu-Bureau, Justine Hugon-Rodin, Lorraine Maitrot-Mantelet & Marianne Canonico. (2013) Hormonal contraceptives and arterial disease: An epidemiological update. Best Practice & Research Clinical Endocrinology & Metabolism 27:1, pages 35-45.
Crossref
Genevieve Plu-Bureau, Lorraine Maitrot-Mantelet, Justine Hugon-Rodin & Marianne Canonico. (2013) Hormonal contraceptives and venous thromboembolism: An epidemiological update. Best Practice & Research Clinical Endocrinology & Metabolism 27:1, pages 25-34.
Crossref
Sophie Christin-Maitre, Emmanuelle Laroche & Léopoldine Bricaire. (2013) A New Contraceptive Pill Containing 17β-Estradiol and Nomegestrol Acetate. Women's Health 9:1, pages 13-23.
Crossref
Katherine A. Lyseng-Williamson, Lily P. H. Yang & Greg L. Plosker. (2012) Nomegestrol acetate/estradiol: a guide to its use in oral contraception. Drugs & Therapy Perspectives 29:1, pages 1-6.
Crossref
Lily P.H. Yang & Greg L. Plosker. (2012) Nomegestrol Acetate/Estradiol. Drugs 72:14, pages 1917-1928.
Crossref
A. Vincent-Rohfritsch, E. Pernin & N. Chabbert-Buffet. (2012) Nouveaut?s en contraception. La Revue Sage-Femme 11:3, pages 150-157.
Crossref
Xiangyan Ruan, Harald Seeger & Alfred O. Mueck. (2012) The pharmacology of nomegestrol acetate. Maturitas 71:4, pages 345-353.
Crossref
A. Vincent-Rohfritsch, E. Pernin & N. Chabbert-Buffet. (2012) Nouveautés en contraception. Journal de Gynécologie Obstétrique et Biologie de la Reproduction 41:2, pages 108-114.
Crossref
F. Trémollieres. (2012) Contraception orale estro-progestative : quelle différence entre éthinylestradiol et estradiol ?. Gynécologie Obstétrique & Fertilité 40:2, pages 109-115.
Crossref
Harry A van Diepen. (2012) Preclinical pharmacological profile of nomegestrol acetate, a synthetic 19-nor-progesterone derivative. Reproductive Biology and Endocrinology 10:1, pages 85.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.